Supplier · United States
Emergent Product Development Gaithersburg Inc.
Updated
Emergent Product Development Gaithersburg Inc. is named in U.S.
About
Emergent Product Development Gaithersburg Inc. is named in U.S. Department of Health and Human Services contracts for medical countermeasures. The original contracts identify its work on the AV7909/NuThrax next-generation anthrax vaccine and ACAM2000 smallpox vaccine.
Sources3
- 1Government recordSAM.gov November1,2026 official public monthly exact-UEI identity
U.S. General Services Administration · Supports Organization · country, Organization · description, Organization · legal name
“CNPVCR8DK7M8 […] EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. […] 300 PROFESSIONAL DR […] GAITHERSBURG […] 20879 […] USA”
- 2Government recordOriginal HHS next-generation anthrax vaccine contract
U.S. Department of Health and Human Services, filed by Emergent via SEC · Supports Organization · description, Organization · legal name
“Emergent Product Development Gaithersburg Inc. is developing NuThrax vaccine as a next generation anthrax vaccine. […] Manufacturing Development and Procurement of AV7909 […] 300 PROFESSIONAL DR # 100 GAITHERSBURG MD 208793419”
- 3Government recordOriginal HHS contract amendment names separate Gaithersburg contractor and smallpox vaccine
U.S. Department of Health and Human Services, filed by Emergent via SEC · Supports Organization · description, Organization · legal name
“EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. […] 300 PROFESSIONAL DR GAITHERSBURG MD 208793419 […] ACAM2000, Smallpox (Vaccinia) Vaccine, Live (ACAM) […] 09/29/2021”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.
